Introduction Interstitial lung disease (ILD) is a serious extra-articular manifestation of rheumatoid arthritis (RA) associated with increased morbidity and mortality. The pulmonary safety of biologic ...

Many people who live with depression say that the hardest part is not just feeling sad, but feeling stuck. Simple tasks like getting out of bed, taking a shower, or going for a short walk can feel ...

Growing evidence has demonstrated that low-dose radiation can target inflammation and reduce pain for osteoarthritis patients ...

Osteoarthritis, a condition that causes pain and reduced mobility in joints such as the knees and fingers, is one of the most common joint disorders worldwide, particularly among aging populations.

Therapeutic drug monitoring would seem like an obvious match with rheumatology. Patients with clinically challenging ...

New disease-modifying anti-rheumatic drugs (DMARDs) for rheumatoid arthritis are usually expensive and insurers, including Medicare, will often limit access. This study examined Medicare Advantage and ...

Siemens Healthineers announced that its Varian TrueBeam radiotherapy systems, which include TrueBeam, TrueBeam STx, VitalBeam, and Edge, have received FDA 510(k) clearance for the use of low-dose ...

Osteoarthritis (OA) is the leading cause of mobility loss in older adults, yet OA care still too often follows a “one-size-fits-all” script—treat pain, ...

Understanding the type of arthritis, its causes, and management options is the first step toward living well with the condition.

RA can affect your lifespan in various ways related to cardiovascular disease, lung disease, infection, depression, and ...

Up to 30% of children with juvenile arthritis develop uveitis, an eye inflammation that can damage vision. New research highlights immune cells as treatment targets.

The US Food and Drug Administration (FDA) has accepted for review Sun Pharmaceutical’s supplemental biologics licence application (sBLA) submitted for Ilumya (tildrakizumab-asmn ...